Vanguard Group’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$22.2M Buy
2,984,927
+60,139
+2% +$432K ﹤0.01% 2573
2025
Q3
$19.6M Buy
2,924,788
+122,749
+4% +$852K ﹤0.01% 2640
2025
Q2
$18.5M Buy
2,802,039
+247,815
+10% +$1.76M ﹤0.01% 2592
2025
Q1
$23.4M Buy
2,554,224
+92,143
+4% +$920K ﹤0.01% 2440
2024
Q4
$25.9M Buy
2,462,081
+388,174
+19% +$4.59M ﹤0.01% 2463
2024
Q3
$24.8M Buy
2,073,907
+413,241
+25% +$3.57M ﹤0.01% 2485
2024
Q2
$9.55M Buy
1,660,666
+442,166
+36% +$2.43M ﹤0.01% 2956
2024
Q1
$6.34M Hold
1,218,500
﹤0.01% 3199
2023
Q4
$6.42M Buy
1,218,500
+17,420
+1% +$68.9K ﹤0.01% 3185
2023
Q3
$3.96M Buy
1,201,080
+5,668
+0.5% +$19.9K ﹤0.01% 3343
2023
Q2
$3.45M Sell
1,195,412
-136,020
-10% -$261K ﹤0.01% 3466
2023
Q1
$1.42M Sell
1,331,432
-14,899
-1% -$28.5K ﹤0.01% 3796
2022
Q4
$3.51M Buy
1,346,331
+162,425
+14% +$709K ﹤0.01% 3455
2022
Q3
$8.29M Buy
1,183,906
+191,671
+19% +$1.5M ﹤0.01% 3053
2022
Q2
$6.77M Sell
992,235
-128,829
-11% -$1.31M ﹤0.01% 3202
2022
Q1
$15.8M Sell
1,121,064
-435,365
-28% -$5.83M ﹤0.01% 2905
2021
Q4
$22.6M Buy
1,556,429
+752,650
+94% +$10.7M ﹤0.01% 2772
2021
Q3
$11.4M Buy
803,779
+286,286
+55% +$4.41M ﹤0.01% 3163
2021
Q2
$9.11M Buy
517,493
+303,495
+142% +$4.89M ﹤0.01% 3256
2021
Q1
$3.27M Buy
+213,998
New +$3.05M ﹤0.01% 3726

Other funds holding BVS